Rafferty Asset Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-306,233
| Closed | -$5.68M | – | 1109 |
|
|
2023
Q3 | $5.68M | Sell |
306,233
-106,041
| -26% | -$1.97M | 0.03% | 364 |
|
|
2023
Q2 | $4.56M | Buy |
412,274
+151,849
| +58% | +$1.68M | 0.03% | 434 |
|
|
2023
Q1 | $3.5M | Sell |
260,425
-5,492
| -2% | -$73.8K | 0.02% | 474 |
|
|
2022
Q4 | $3.29M | Buy |
265,917
+40,313
| +18% | +$499K | 0.03% | 462 |
|
|
2022
Q3 | $3.15M | Buy |
225,604
+72,411
| +47% | +$1.01M | 0.03% | 407 |
|
|
2022
Q2 | $2.12M | Sell |
153,193
-74,650
| -33% | -$1.03M | 0.02% | 449 |
|
|
2022
Q1 | $3.71M | Sell |
227,843
-31,996
| -12% | -$521K | 0.02% | 448 |
|
|
2021
Q4 | $4.23M | Buy |
259,839
+112,239
| +76% | +$1.83M | 0.02% | 448 |
|
|
2021
Q3 | $2.19M | Buy |
147,600
+26,609
| +22% | +$395K | 0.02% | 616 |
|
|
2021
Q2 | $2.42M | Sell |
120,991
-37,601
| -24% | -$751K | 0.02% | 622 |
|
|
2021
Q1 | $3.66M | Buy |
158,592
+128,237
| +422% | +$2.96M | 0.03% | 371 |
|
|
2020
Q4 | $750K | Sell |
30,355
-17,226
| -36% | -$426K | 0.01% | 590 |
|
|
2020
Q3 | $1.97M | Buy |
47,581
+34,877
| +275% | +$1.45M | 0.02% | 421 |
|
|
2020
Q2 | $609K | Buy |
12,704
+8,846
| +229% | +$424K | 0.01% | 666 |
|
|
2020
Q1 | $243K | Sell |
3,858
-29,007
| -88% | -$1.83M | 0.01% | 484 |
|
|
2019
Q4 | $4.07M | Sell |
32,865
-61,232
| -65% | -$7.59M | 0.06% | 160 |
|
|
2019
Q3 | $6.24M | Buy |
94,097
+31,921
| +51% | +$2.12M | 0.1% | 120 |
|
|
2019
Q2 | $4.95M | Buy |
62,176
+13,041
| +27% | +$1.04M | 0.09% | 168 |
|
|
2019
Q1 | $5.5M | Buy |
+49,135
| New | +$5.5M | 0.09% | 123 |
|